Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 1 7Phase EARLY_PHASE1 4Phase NA 2Phase 1/2 2Phase 3 1

Status

Completed 2

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Endocrine 2NET 1CNS 1

Conditions

Pheochromocytoma 1Neuroendocrine Tumors 1Neuroblastoma 1

Interventions

Exercise 419Blood Specimen Collection 319Standard of Care 299Surveys and Questionnaires 242Radiosurgery 239Magnetic Resonance Spectroscopy 232Educational Status 223Methods 221Radiotherapy 216Early Intervention, Educational 200Interviews as Topic 142Practice Guidelines as Topic 141Biopsy 125Surgical Procedures, Operative 119Drug Therapy 119Acupuncture Therapy 119Control Groups 115Therapeutics 101Palliative Care 97Resistance Training 94Counseling 88Saline Solution 87Magnetic Resonance Imaging 84Cyclophosphamide 83Specimen Handling 73Cisplatin 73Radiofrequency Ablation 71Cognitive Behavioral Therapy 71Radiotherapy, Intensity-Modulated 68Colonoscopy 65

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × OTHER × 3-Iodobenzylguanidine × Clear all
NCT01850888 2025-12-18

MIBG for Refractory Neuroblastoma and Pheochromocytoma

Masonic Cancer Center, University of Minnesota

Phase NA Completed
15 enrolled
CNSEndocrine

Neuroblastoma, Pheochromocytoma

NCT01099228 2016-07-21

Combination Targeted Radiotherapy in Neuroendocrine Tumors

University of Iowa

Phase NA Completed
2 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡